An Open, Single Centre, Phase I Study in Male Adolescents With Asthma, Aged 12 to 17 Years, to Assess Pharmacokinetics of Orally Administered AZD1981 Tablets 100 mg Twice Daily for 61/2 Days.

Trial Profile

An Open, Single Centre, Phase I Study in Male Adolescents With Asthma, Aged 12 to 17 Years, to Assess Pharmacokinetics of Orally Administered AZD1981 Tablets 100 mg Twice Daily for 61/2 Days.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2013

At a glance

  • Drugs AZD 1981 (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Acronyms PEAK
  • Most Recent Events

    • 21 Sep 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2010-021520-10).
    • 04 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jan 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top